Source: TradeTheNews Upside – $VTGN +59.5% (extends the prior-session rally after preliminary PALISADE-4 open-label extension data for fasedienol in social anxiety disorder) – $GRML +24.0% (no clear fresh catalyst identified; exceptionally heavy-volume small-cap move) – $WOR +15.5% (Q1 beat as stronger Building Products results and data-center demand lifted performance) – $TLSI +15.0% (FDA grants 510(k) …
Read in context ›Astrana Health Stock (ASTH)
Track Astrana Health stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
ASTH
Astrana Health
healthcare
At close
$36.37
â–² +1.93 (+5.60%)
Sep 25, 4:00 PM ET
After-hours
$36.37
• +0.00 (0.00%)
Sep 25, 7:30 PM ET
Market Cap
$1.80B
P/E Ratio
43.9x
1Y Return
+30.45%
EPS (TTM)
$0.82
Read the latest TheStreet Pro articles mentioning Astrana Health, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning ASTH yet.
Daily Diary Mentions
1 mentionUpside, Downside Movers in the Morning